3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Glioblastoma
23
Breast Neoplasms
22
Carcinoma, Non-Small-Cell Lung
17
Rectal Neoplasms
13
Prostatic Neoplasms
13
Gliosarcoma
12
Lung Neoplasms
10
Head and Neck Neoplasms
10
Esophageal Neoplasms
10
Brain Neoplasms
10
Neoplasms
9
Uterine Cervical Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
8
Adenocarcinoma Of Esophagus
8
Sarcoma
7
Neoplasm Metastasis
7
Central Nervous System Neoplasms
7
Pancreatic Neoplasms
6
Melanoma
6
Glioma
6
Carcinoma, Squamous Cell
6
Astrocytoma
6
Urinary Bladder Neoplasms
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Burkitt Lymphoma
5
Oropharyngeal Neoplasms
4
Medulloblastoma
4
Lymphoma, Follicular
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Myeloid, Acute
4
Interventions
Radiotherapy
3
Carboplatin
3
Trastuzumab
2
Magnetic Resonance Spectroscopy
2
Cyclophosphamide
2
proto-oncogene protein c-fes-fps
1
palbociclib
1
gallium 68 PSMA-11
1
fluciclovine F-18
1
Vorinostat
1
Thiotepa
1
Taxes
1
Tamoxifen
1
Sugars
1
Radiation
1
Paclitaxel
1
Naltrexone
1
Melphalan
1
Letrozole
1
Fulvestrant
1
Fluorine-18
1
Drugs, Generic
1
Doxorubicin
1
Docetaxel
1
Crizotinib
1
Counseling
1
Chemotherapy, Adjuvant
1
Albumin-Bound Paclitaxel
1
68Ga-DKFZ-PSMA-11
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Lobular
×
Radiation
×
Clear all
NCT01819233
2025-06-06
CAREFOR
Thomas Jefferson University
Phase NA
Completed
38 enrolled
10 charts